Generifar S.A.

Generifar S.A. is a leading Nicaraguan pharmaceutical company dedicated to the manufacture and distribution of generic medications for human consumption. Founded in 1997, the company has developed a strong identity in the local market and has successfully expanded its reach into Central America and the Caribbean. It operates a manufacturing plant in Managua that adheres to Good Manufacturing Practices (BPM/GMP) standards. The company's business model includes the production of its own generic brand and the provision of contract manufacturing (Maquila) services. These services range from traditional manufacturing (MT) to value-added manufacturing (MVA), allowing regional partners to leverage Generifar's production capabilities. The company is known for its commitment to providing accessible, high-quality healthcare solutions and maintains close ties with regional health authorities and international development organizations like IDB Invest.